Phase II Randomized Study Comparing the Association of Intraarterial Perfusion of Raltitrexed and Oxaliplatin Versus Standard Chemotherapy Using Intravenous Perfusion for Colorectal Cancer Patient With Metastases Localized to Liver After Failure of Conventional Treatments
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Raltitrexed (Primary) ; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms HEARTO
- 19 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 18 May 2019.
- 22 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.
- 04 Dec 2014 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.